Literature DB >> 35158150

Brain Magnetic Resonance Imaging and Angiography in Children with Sickle Cell Anaemia in Uganda in a Cross-Sectional Sample.

Richard Idro1, Amelia K Boehme2, Michael Kawooya3, Samson K Lubowa4, Deogratias Munube1, Paul Bangirana5, Robert Opoka1, Ezekiel Mupere1, Angela Lignelli6, Philip Kasirye1, Nancy S Green7, Frank J Minja8.   

Abstract

OBJECTIVE: Children with sickle cell anaemia (SCA) are highly susceptible to cerebrovascular injury. We performed brain magnetic resonance imaging and angiography (MRI-MRA) in Ugandan children with SCA to identify structural cerebrovascular abnormalities and examine their relationship to standardized clinical assessments.
METHODS: A sub-sample (n=81) was selected from a cross-sectional study of children attending SCA clinic, including 52 (64.2%) with and 29 (35.8%) without clinically detected abnormalities. Clinical evaluation included assessment for prior stroke, cognitive testing and cerebral arterial transcranial doppler (TCD) flow velocity. MRI-MRA scans were interpreted by at least two neuroradiologists.
RESULTS: Mean age was 6.5±2.7 years, with 39 (48.1%) female. Mean haemoglobin was 7.3±0.9 g/dl. Overall, 13 (16.0%) were malnourished. Infarcts and/or stenoses were detected in 55 (67.9%) participants, with stenoses primarily in the anterior circulation. Infarcts were seen in those with normal 17/29 (58.6%) or abnormal 34/52 (65.4%) clinical testing (p=0.181). Neither abnormal MRI nor MRA was associated with age, sex, haemoglobin, or malnutrition. Abnormal MRA was highly associated with infarcts (p<0.0001). Participants with abnormal imaging had two-fold higher proportion of stroke on exam and/or impaired cognition. Stroke on exam was strongly associated with an imaging abnormality after adjusting for age, sex, malnutrition, and haemoglobin (OR 11.8, 95%CI 1.87-74.2).
CONCLUSION: Over half of these SCA children had cerebrovascular infarcts and/or arterial stenoses. Cerebrovascular disease was frequently undetectable by clinical assessments. While rarely available in under-resourced settings, MRI-MRA brain imaging is an important tool for defining SCA cerebrovascular disease and for assessing impact of clinical intervention trials.
Copyright © 2022 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Magnetic resonance imaging; Pediatrics; Sickle cell; Silent infarct; Stroke

Mesh:

Year:  2022        PMID: 35158150      PMCID: PMC9004405          DOI: 10.1016/j.jstrokecerebrovasdis.2022.106343

Source DB:  PubMed          Journal:  J Stroke Cerebrovasc Dis        ISSN: 1052-3057            Impact factor:   2.136


  40 in total

Review 1.  Advances in Understanding Ischemic Stroke Physiology and the Impact of Vasculopathy in Children With Sickle Cell Disease.

Authors:  Kristin P Guilliams; Melanie E Fields; Michael M Dowling
Journal:  Stroke       Date:  2019-02       Impact factor: 7.914

Review 2.  Central nervous system complications and management in sickle cell disease.

Authors:  Michael R DeBaun; Fenella J Kirkham
Journal:  Blood       Date:  2016-01-12       Impact factor: 22.113

Review 3.  Sickle Cell Disease and Stroke.

Authors:  Deborah Hirtz; Fenella J Kirkham
Journal:  Pediatr Neurol       Date:  2019-02-27       Impact factor: 3.372

4.  Ischemic stroke in children and young adults with sickle cell disease in the post-STOP era.

Authors:  Janet L Kwiatkowski; Jenifer H Voeks; Julie Kanter; Heather J Fullerton; Ellen Debenham; Lynette Brown; Robert J Adams
Journal:  Am J Hematol       Date:  2019-11-01       Impact factor: 10.047

5.  Abnormal transcranial Döppler ultrasonography in children with sickle cell disease.

Authors:  Ana Claudia Celestino Bezerra Leite; Raquel Vasconcellos Carvalhaes de Oliveira; Patrícia Gomes de Moura; Célia Maria Silva; Clarisse Lobo
Journal:  Rev Bras Hematol Hemoter       Date:  2012

6.  Neurocognitive domains affected by cerebral malaria and severe malarial anemia in children.

Authors:  Paul Bangirana; Robert O Opoka; Michael J Boivin; Richard Idro; James S Hodges; Chandy C John
Journal:  Learn Individ Differ       Date:  2015-01-16

7.  Sickle cell disease in Africa: a neglected cause of early childhood mortality.

Authors:  Scott D Grosse; Isaac Odame; Hani K Atrash; Djesika D Amendah; Frédéric B Piel; Thomas N Williams
Journal:  Am J Prev Med       Date:  2011-12       Impact factor: 5.043

8.  Stroke Prevalence in Children With Sickle Cell Disease in Sub-Saharan Africa: A Systematic Review and Meta-Analysis.

Authors:  Lianna J Marks; Deogratias Munube; Philip Kasirye; Ezekiel Mupere; Zhezhen Jin; Philip LaRussa; Richard Idro; Nancy S Green
Journal:  Glob Pediatr Health       Date:  2018-05-14

9.  American Society of Hematology 2020 guidelines for sickle cell disease: prevention, diagnosis, and treatment of cerebrovascular disease in children and adults.

Authors:  M R DeBaun; L C Jordan; A A King; J Schatz; E Vichinsky; C K Fox; R C McKinstry; P Telfer; M A Kraut; L Daraz; F J Kirkham; M H Murad
Journal:  Blood Adv       Date:  2020-04-28

10.  Burden of neurological and neurocognitive impairment in pediatric sickle cell anemia in Uganda (BRAIN SAFE): a cross-sectional study.

Authors:  Nancy S Green; Deogratias Munube; Paul Bangirana; Linda Rosset Buluma; Bridget Kebirungi; Robert Opoka; Ezekiel Mupere; Philip Kasirye; Sarah Kiguli; Annet Birabwa; Michael S Kawooya; Samson K Lubowa; Rogers Sekibira; Edwards Kayongo; Heather Hume; Mitchell Elkind; Weixin Peng; Gen Li; Caterina Rosano; Philip LaRussa; Frank J Minja; Amelia Boehme; Richard Idro
Journal:  BMC Pediatr       Date:  2019-10-25       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.